{"2411.02466": {"publish_time": "2024-11-04", "title": "Weakly supervised deep learning model with size constraint for prostate cancer detection in multiparametric MRI and generalization to unseen domains", "paper_summary": "Fully supervised deep models have shown promising performance for many\nmedical segmentation tasks. Still, the deployment of these tools in clinics is\nlimited by the very timeconsuming collection of manually expert-annotated data.\nMoreover, most of the state-ofthe-art models have been trained and validated on\nmoderately homogeneous datasets. It is known that deep learning methods are\noften greatly degraded by domain or label shifts and are yet to be built in\nsuch a way as to be robust to unseen data or label distributions. In the\nclinical setting, this problematic is particularly relevant as the deployment\ninstitutions may have different scanners or acquisition protocols than those\nfrom which the data has been collected to train the model. In this work, we\npropose to address these two challenges on the detection of clinically\nsignificant prostate cancer (csPCa) from bi-parametric MRI. We evaluate the\nmethod proposed by (Kervadec et al., 2018), which introduces a size constaint\nloss to produce fine semantic cancer lesions segmentations from weak circle\nscribbles annotations. Performance of the model is based on two public (PI-CAI\nand Prostate158) and one private databases. First, we show that the model\nachieves on-par performance with strong fully supervised baseline models, both\non in-distribution validation data and unseen test images. Second, we observe a\nperformance decrease for both fully supervised and weakly supervised models\nwhen tested on unseen data domains. This confirms the crucial need for\nefficient domain adaptation methods if deep learning models are aimed to be\ndeployed in a clinical environment. Finally, we show that ensemble predictions\nfrom multiple trainings increase generalization performance.", "paper_summary_zh": "<paragraph>\u5b8c\u5168\u76e3\u7763\u7684\u6df1\u5ea6\u6a21\u578b\u5728\u8a31\u591a\u91ab\u7642\u5f71\u50cf\u5206\u5272\u4efb\u52d9\u4e2d\u5c55\u73fe\u51fa\u826f\u597d\u7684\u6548\u80fd\u3002\u7136\u800c\uff0c\u9019\u4e9b\u5de5\u5177\u5728\u81e8\u5e8a\u4e0a\u7684\u90e8\u7f72\u53d7\u5230\u8017\u6642\u7684\u4eba\u5de5\u6a19\u8a18\u8cc7\u6599\u8490\u96c6\u9650\u5236\u3002\u6b64\u5916\uff0c\u5927\u591a\u6578\u6700\u5148\u9032\u7684\u6a21\u578b\u90fd\u5728\u4e2d\u7b49\u540c\u8cea\u7684\u8cc7\u6599\u96c6\u4e0a\u8a13\u7df4\u548c\u9a57\u8b49\u3002\u773e\u6240\u5468\u77e5\uff0c\u6df1\u5ea6\u5b78\u7fd2\u65b9\u6cd5\u7d93\u5e38\u6703\u56e0\u9818\u57df\u6216\u6a19\u7c64\u8f49\u79fb\u800c\u5927\u5e45\u964d\u4f4e\uff0c\u800c\u4e14\u5c1a\u672a\u5efa\u69cb\u51fa\u5c0d\u672a\u898b\u8cc7\u6599\u6216\u6a19\u7c64\u5206\u4f48\u5177\u6709\u7a69\u5065\u6027\u7684\u65b9\u6cd5\u3002\u5728\u81e8\u5e8a\u74b0\u5883\u4e2d\uff0c\u9019\u500b\u554f\u984c\u7279\u5225\u76f8\u95dc\uff0c\u56e0\u70ba\u90e8\u7f72\u6a5f\u69cb\u53ef\u80fd\u64c1\u6709\u8207\u7528\u65bc\u8a13\u7df4\u6a21\u578b\u7684\u8cc7\u6599\u4e0d\u540c\u7684\u6383\u63cf\u5668\u6216\u64f7\u53d6\u5354\u5b9a\u3002\u5728\u9019\u9805\u5de5\u4f5c\u4e2d\uff0c\u6211\u5011\u63d0\u8b70\u91dd\u5c0d\u5f9e\u96d9\u53c3\u6578 MRI \u4e2d\u5075\u6e2c\u81e8\u5e8a\u986f\u8457\u7684\u524d\u5217\u817a\u764c (csPCa) \u4f86\u89e3\u6c7a\u9019\u5169\u500b\u6311\u6230\u3002\u6211\u5011\u8a55\u4f30\u7531 (Kervadec \u7b49\u4eba\uff0c2018 \u5e74) \u63d0\u51fa\uff0c\u4e26\u5f15\u5165\u5927\u5c0f\u7d04\u675f\u640d\u5931\u7684\u65b9\u6cd5\uff0c\u4ee5\u5f9e\u5f31\u5713\u5f62\u5857\u9d09\u6a19\u8a3b\u4e2d\u7522\u751f\u7cbe\u7d30\u7684\u8a9e\u7fa9\u764c\u75c7\u75c5\u7076\u5206\u5272\u3002\u6a21\u578b\u7684\u6548\u80fd\u57fa\u65bc\u5169\u500b\u516c\u958b\u8cc7\u6599\u5eab (PI-CAI \u548c Prostate158) \u548c\u4e00\u500b\u79c1\u4eba\u8cc7\u6599\u5eab\u3002\u9996\u5148\uff0c\u6211\u5011\u5c55\u793a\u8a72\u6a21\u578b\u5728\u5206\u4f48\u5167\u9a57\u8b49\u8cc7\u6599\u548c\u672a\u898b\u6e2c\u8a66\u5f71\u50cf\u4e0a\u90fd\u9054\u5230\u8207\u5f37\u5927\u7684\u5b8c\u5168\u76e3\u7763\u57fa\u7dda\u6a21\u578b\u540c\u7b49\u7684\u6548\u80fd\u3002\u5176\u6b21\uff0c\u6211\u5011\u89c0\u5bdf\u5230\u5728\u672a\u898b\u8cc7\u6599\u9818\u57df\u4e0a\u6e2c\u8a66\u6642\uff0c\u5b8c\u5168\u76e3\u7763\u548c\u5f31\u76e3\u7763\u6a21\u578b\u7684\u6548\u80fd\u90fd\u6703\u4e0b\u964d\u3002\u9019\u8b49\u5be6\u4e86\u5c0d\u6709\u6548\u9818\u57df\u9069\u61c9\u65b9\u6cd5\u7684\u8feb\u5207\u9700\u6c42\uff0c\u5982\u679c\u6df1\u5ea6\u5b78\u7fd2\u6a21\u578b\u65e8\u5728\u90e8\u7f72\u5728\u81e8\u5e8a\u74b0\u5883\u4e2d\u3002\u6700\u5f8c\uff0c\u6211\u5011\u5c55\u793a\u4f86\u81ea\u591a\u91cd\u8a13\u7df4\u7684\u6574\u9ad4\u9810\u6e2c\u6703\u63d0\u5347\u6982\u5316\u6548\u80fd\u3002</paragraph>", "author": "Robin Trombetta et.al.", "authors": "Robin Trombetta, Olivier Rouvi\u00e8re, Carole Lartizien", "id": "2411.02466v1", "paper_url": "http://arxiv.org/abs/2411.02466v1", "repo": "null"}}